<DOC>
	<DOC>NCT00062673</DOC>
	<brief_summary>A study of the safety and efficacy of duloxetine in elderly patients (greater than 65 years old) with major depressive disorder</brief_summary>
	<brief_title>Study of Duloxetine in Elderly Patients With Major Depressive Disorder</brief_title>
	<detailed_description>Duloxetine 60 mg QD and placebo variable-duration, placebo lead-in period 9 weeks in the acute treatment phase</detailed_description>
	<mesh_term>Depressive Disorder</mesh_term>
	<mesh_term>Depression</mesh_term>
	<mesh_term>Depressive Disorder, Major</mesh_term>
	<mesh_term>Duloxetine Hydrochloride</mesh_term>
	<criteria>You must be able to visit the doctor's office for clinic visits, tests, and procedures. You must have been diagnosed with major depression, and have had at least one other episode in the past. You have a current or previous major psychiatric disorder other than depression, such as bipolar disorder, schizophrenia, or other psychotic disorder. You have taken a drug within the last 30 days that has not been approved for use by governmental authorities.</criteria>
	<gender>All</gender>
	<minimum_age>65 Years</minimum_age>
	<maximum_age>N/A</maximum_age>
	<verification_date>May 2007</verification_date>
</DOC>